Optimal usage of radium-223 in metastatic castration-resistant prostate cancer

被引：14
|
作者：
Cha, Tai-Lung [1 ]
Wu, Tony Tong-Lin [2 ]
Vogelzang, Nicholas John [3 ,13 ]
Huang, Chao-Yuan [4 ]
Huang, Shu-Pin [5 ]
Lin, Chia-Chi [6 ]
Ou, Yen-Chuan [7 ]
Pang, See-Tong [8 ]
Shen, Daniel Heung-Yuan [9 ]
Wu, Wen-Jeng [10 ]
Chang, Wayne Yen-Hwa [11 ,12 ]
机构：
[1] Natl Def Med Ctr, Div Urol, Dept Surg, Triserv Gen Hosp, Taipei, Taiwan
[2] Kaohsiung Vet Gen Hosp, Div Urol, Dept Surg, Kaohsiung, Taiwan
[3] Univ Nevada, Sch Med, Med Oncol Comprehens Canc Ctr Nevada, Las Vegas, NV 89154 USA
[4] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan
[5] Kaohsiung Med Univ, Dept Urol, Chung Ho Mem Hosp, Kaohsiung, Taiwan
[6] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
[7] Taichung Vet Gen Hosp, Div Urol, Dept Surg, Taichung, Taiwan
[8] Chang Gung Mem Hosp, Div Urol, Dept Surg, Linkou, Taiwan
[9] Natl Def Med Ctr, Dept Nucl Med, Triserv Gen Hosp, Taipei, Taiwan
[10] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Urol, Chung Ho Mem Hosp, Kaohsiung, Taiwan
[11] Taipei Vet Gen Hosp, Div Gen Urol, Dept Urol, Taipei, Taiwan
[12] Natl Yang Ming Univ, Dept Urol, Sch Med, Taipei, Taiwan
[13] Comprehens Canc Ctr Nevada, 3730 S Eastern Ave, Las Vegas, NV 89169 USA
来源：
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2017年 / 116卷 / 11期
关键词：
Radium chloride Ra 223; Radiopharmaceuti-cals; PAINFUL BONE METASTASES; DOUBLE-BLIND; CLINICAL-EXPERIENCE; PHASE-III; CHLORIDE; SURVIVAL; THERAPY; MULTICENTER; PALLIATION; DICHLORIDE;
D O I：
10.1016/j.jfma.2017.04.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Radium-223 is a first-in-class alpha-emitting radiopharmaceutical that targets bone metastases associated with metastatic castration-resistant prostate cancer (mCRPC). In the pivotal phase III trial ALSYMPCA, radium-223 significantly increased overall survival (OS), compared with placebo (median 14.9 vs 11.3 months; hazard ratio 0.70; 95% CI 0.58-0.83; p < 0.001), in patients with mCRPC and symptomatic bone metastasese-with a comparable safety profile.
引用
收藏
页码：825 / 836
页数：12
相关论文
共 50 条
  • [31] Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223
    A. Rodriguez-Vida
    M. D. Torregrosa
    Á. Pinto
    M. Á. Climent
    D. Olmos
    J. Carles
    Clinical and Translational Oncology, 2018, 20 : 679 - 686
  • [32] When to Initiate Treatment With Radium-223 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Shore, Neal D.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) : 26 - 29
  • [33] RADIUM 223 FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Miranda, Jesus
    Vinal, David
    Pinto, Alvaro
    ARCHIVOS ESPANOLES DE UROLOGIA, 2019, 72 (05): : 500 - 507
  • [34] Combination Therapy With Radium-223 and Enzalutamide in Castration-Resistant Prostate Cancer
    Maughan, Benjamin L.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (12) : 764 - 766
  • [35] Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer - role of radium-223
    Mukherji, Deborah
    El Dika, Imane
    Temraz, Sally
    Haidar, Mohammed
    Shamseddine, Ali
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 373 - 380
  • [36] Radium-223 Dichloride in Peritoneal Dialysate Following Treatment of Metastatic Castration-resistant Prostate Cancer
    Saganich, Christopher
    Zgaljardic, Michael
    HEALTH PHYSICS, 2022, 122 (03): : 433 - 439
  • [37] High-Dose Testosterone and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
    Christensen, Bryce Raymon
    Barata, Pedro C.
    Ledet, Elisa M.
    Layton, Jodi L.
    Lewis, Brian E.
    Sartor, Oliver
    CLINICAL GENITOURINARY CANCER, 2019, 17 (06) : 476 - 479
  • [38] Radium-223 in patients with metastatic castration-resistant prostate cancer: Efficacy and safety in clinical practice
    Prelaj, Arsela
    Rebuzzi, Sara Elena
    Buzzacchino, Federica
    Pozzi, Chiara
    Ferrara, Carla
    Frantellizzi, Viviana
    Follacchio, Giulia Anna
    Civitelli, Liana
    De Vincentis, Giuseppe
    Tomao, Silverio
    Bianco, Vincenzo
    ONCOLOGY LETTERS, 2019, 17 (02) : 1467 - 1476
  • [39] Lymph Node Response in a Patient With Metastatic Castration-resistant Prostate Cancer Treated With Radium-223
    Poon, Darren M. C.
    Wong, Kenneth C. W.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : E397 - E401
  • [40] DNA Repair Pathway Alterations in Metastatic Castration-resistant Prostate Cancer Responders to Radium-223
    Ramos, Jorge D.
    Mostaghel, Elahe A.
    Pritchard, Colin C.
    Yu, Evan Y.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : 106 - 110
12345